Item request has been placed!
×
Item request cannot be made.
×
Processing Request
A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
- Publication Information:
Publication: 2000- : New York : Elsevier
Original Publication: Rochester, Minn., American Academy of Ophthalmology.
- Subject Terms:
- Accession Number:
0 (Antibodies, Monoclonal, Humanized)
EC 2.7.10.1 (Receptor, IGF Type 1)
Y64GQ0KC0A (teprotumumab)
- Publication Date:
Date Created: 20210407 Date Completed: 20211122 Latest Revision: 20211122
- Publication Date:
20231215
- Accession Number:
10.1016/j.ophtha.2021.03.006
- Accession Number:
33823982
No Comments.